Streetbeat News

Earnings

TWO

Two Harbors Investment Corp reported its Q3 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 2:46 pm

SSTK

Shutterstock has reported better-than-expected Q3 financial results and raised its FY23 guidance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 2:45 pm

ASO

BZH

DBGI

FGI

VNCE

Benzinga Insights has identified five value stocks in the consumer cyclical sector that may be worth watching: Academy Sports (ASO), Beazer Homes USA (BZH), Digital Brands Group (DBGI), Vince Holding (VNCE), and FGI Industries (FGI). All these companies have low P/E multiples, indicating they may be undervalued. This quarter, ASO, DBGI, and FGI have seen an increase in earnings per share, while BZH and VNCE have reported earnings per share for Q3.

Portfolio Pulse from Benzinga Insights

October 31, 2023 | 2:44 pm

AVT

BELFB

DIOD

JKS

PLAB

The article lists five value stocks in the technology sector that may be undervalued. These include Bel Fuse (NASDAQ:BELFB), Photronics (NASDAQ:PLAB), Diodes (NASDAQ:DIOD), Avnet (NASDAQ:AVT), and JinkoSolar Holding Co (NYSE:JKS). The companies have shown varying performance in their earnings per share (EPS) and dividend yields in the recent quarters.

Portfolio Pulse from Benzinga Insights

October 31, 2023 | 2:41 pm

CAT

Caterpillar Inc (NYSE:CAT) reported a 12% YoY increase in Q3 FY23 revenue to $16.81 billion, beating the consensus of $16.59 billion. Adjusted earnings were $5.52 per share, compared to $3.95 a year ago, topping the consensus of $4.79. The company's sales increase was due to favorable price realization and higher sales volume. However, despite the positive earnings report, CAT shares are trading lower by 5.81% at $228.10.

Portfolio Pulse from Akanksha Bakshi

October 31, 2023 | 2:40 pm

GEHC

GE Healthcare Technologies Inc (NASDAQ:GEHC) reported Q3 FY23 sales of $4.82 billion, up 5% Y/Y and 6% on an organic basis, slightly beating the consensus of $4.80 billion. Net income was $375 million, down from $487 million for the prior year. The company posted an adjusted EPS of $0.99, beating the consensus of $0.90. GE Healthcare forecasts FY23 adjusted EPS of $3.75-$3.85 and reaffirms FY23 organic revenue growth of 6%-8% YOY. GEHC shares are up 6.20% to $67.09.

Portfolio Pulse from Vandana Singh

October 31, 2023 | 2:27 pm

MTCH

Match Group Inc (NASDAQ:MTCH) is set to report its Q3 earnings on Oct. 31. The company generates revenue through subscription services, in-app purchases, and advertising. Wall Street analysts expect Match Group to report $0.54 in EPS and $881.14 million in revenue for Q3. The stock is currently trading at a P/E of 12.1. Over the past month, the stock has fallen by over 10% but was trading 1.75% higher to $34.64 at the time of publication.

Portfolio Pulse from Surbhi Jain

October 31, 2023 | 2:24 pm

RIG

Transocean Ltd (NYSE:RIG) shares are trading higher after initially falling due to worse-than-expected Q3 financial results. The company reported Q3 revenue of $713 million, lower than the estimated $722.57 million, and a loss of 36 cents per share, higher than the estimated loss of 23 cents. Despite the disappointing results, the company's contract backlog increased for the sixth consecutive quarter to $9.4 billion.

Portfolio Pulse from Adam Eckert

October 31, 2023 | 2:16 pm

MBUU

Malibu Boats Inc (NASDAQ:MBUU) reported a Q1 FY24 sales decline of 15.3% YoY to $255.83 million, beating analyst consensus. The decrease was due to decreased unit volumes and increased dealer flooring program costs due to higher interest rates and increased inventory levels. The company's operating income fell 40.9% to $28.6 million. The company expects FY24 sales decline in the high teens to low twenties and adjusted EBITDA margin down 350-450 basis points.

Portfolio Pulse from Shivani Kumaresan

October 31, 2023 | 2:13 pm

MYNZ

PFE

Pfizer Inc (NYSE:PFE) reported a Q3 loss due to a 42% YoY contraction in revenues to $13.2 billion, largely due to a $5.6 billion COVID-19-related inventory write-down. However, non-Covid segments showed 10% operational growth, and the company is on track to reach its 2023 targets. Mainz Biomed NV (NASDAQ:MYNZ) reported positive interim results from its colorectal cancer screening campaign in partnership with Zöller-Kipper GmbH.

Portfolio Pulse from Upwallstreet

October 31, 2023 | 2:05 pm